United States · FDA National Drug Code directory
Clobetasol Propionate
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 45802-925_596d1122-15bb-4b30-b175-457ba7933a6e
- Product NDC
- 45802-925
- Form
- GEL
- Composition / generic term
- Clobetasol propionate
- Labeler
- Padagis Israel Pharmaceuticals Ltd
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20080730
- Source listing expiry
- 20261231
Source-listed ingredients
- CLOBETASOL PROPIONATE — .5 mg/g
These values do not establish equivalence or a dose recommendation.
Packages
- 1 TUBE in 1 CARTON (45802-925-14) / 15 g in 1 TUBE · 45802-925-14
- 1 TUBE in 1 CARTON (45802-925-94) / 30 g in 1 TUBE · 45802-925-94
- 1 TUBE in 1 CARTON (45802-925-96) / 60 g in 1 TUBE · 45802-925-96
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →